DE3264316D1 - Vaccine against foot-and-mouth disease and colibacillosis, and process for preparing it - Google Patents

Vaccine against foot-and-mouth disease and colibacillosis, and process for preparing it

Info

Publication number
DE3264316D1
DE3264316D1 DE8282402104T DE3264316T DE3264316D1 DE 3264316 D1 DE3264316 D1 DE 3264316D1 DE 8282402104 T DE8282402104 T DE 8282402104T DE 3264316 T DE3264316 T DE 3264316T DE 3264316 D1 DE3264316 D1 DE 3264316D1
Authority
DE
Germany
Prior art keywords
colibacillosis
preparing
mouth disease
vaccine against
against foot
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8282402104T
Other languages
German (de)
English (en)
Inventor
Philippe Desmettre
Hubert Favre
Michel Riviere
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Animal Health France SAS
Original Assignee
Rhone Merieux SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Merieux SA filed Critical Rhone Merieux SA
Application granted granted Critical
Publication of DE3264316D1 publication Critical patent/DE3264316D1/de
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/025Enterobacteriales, e.g. Enterobacter
    • A61K39/0258Escherichia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5252Virus inactivated (killed)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552Veterinary vaccine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505Inorganic adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55577Saponins; Quil A; QS21; ISCOMS
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/70Multivalent vaccine
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/32011Picornaviridae
    • C12N2770/32111Aphthovirus, e.g. footandmouth disease virus
    • C12N2770/32134Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Microbiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE8282402104T 1981-11-19 1982-11-18 Vaccine against foot-and-mouth disease and colibacillosis, and process for preparing it Expired DE3264316D1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8121676A FR2516385A1 (fr) 1981-11-19 1981-11-19 Vaccin anti-aphteux et anti-colibacillaire et son procede de preparation

Publications (1)

Publication Number Publication Date
DE3264316D1 true DE3264316D1 (en) 1985-07-25

Family

ID=9264165

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8282402104T Expired DE3264316D1 (en) 1981-11-19 1982-11-18 Vaccine against foot-and-mouth disease and colibacillosis, and process for preparing it

Country Status (7)

Country Link
EP (1) EP0080412B1 (enExample)
AR (1) AR229624A1 (enExample)
DE (1) DE3264316D1 (enExample)
ES (1) ES517461A0 (enExample)
FR (1) FR2516385A1 (enExample)
IN (1) IN155663B (enExample)
ZA (1) ZA828574B (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK219084D0 (da) * 1984-05-02 1984-05-02 Frederik Carl Peter Lindberg Antigen

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1488212A (fr) * 1964-06-22 1967-07-13 Behringwerke Ag Procédé permettant d'atténuer le virus de la fièvre aphteuse
LU57465A1 (enExample) * 1968-12-04 1970-06-04
US4140763A (en) * 1976-09-08 1979-02-20 The United States Of America As Represented By The Secretary Of Agriculture Vaccine for foot and mouth disease
US4298597A (en) * 1979-09-04 1981-11-03 University Of Saskatchewan Vaccine for diarrhea caused by E. coli

Also Published As

Publication number Publication date
ES8307499A1 (es) 1983-08-01
AR229624A1 (es) 1983-09-30
ES517461A0 (es) 1983-08-01
EP0080412A1 (fr) 1983-06-01
EP0080412B1 (fr) 1985-06-19
ZA828574B (en) 1984-03-28
IN155663B (enExample) 1985-02-23
FR2516385B1 (enExample) 1984-02-10
FR2516385A1 (fr) 1983-05-20

Similar Documents

Publication Publication Date Title
DE3266201D1 (en) Infectious-bronchitis vaccines for poultry, combined infectious-bronchitis vaccines, process for preparing such vaccines and infectious-bronchitis virus strain
YU316980A (en) Process for preparing 4,1',6'-trichloro-4,1',6'-trideoxy-galactosaccharose
PT76017A (en) Process for preparing benzisothiazole and benzisoxazole piperazine derivatives
HUT41050A (en) Process for preparing synthetic vaccine against foot-and-mouth disease
EP0240015A3 (en) Carbostyril derivatives, process for preparing them, pharmaceutical composition, and use
GR3014958T3 (en) 2,4- and 2,5-Pyridine-dicarboxylic-acid derivatives, process for their preparation, their use and medicines based on these compounds.
DE3477469D1 (en) Enzyme-protein conjugate, process for its preparation and pharmaceutical use thereof
ZA87158B (en) Direct method for preparing syndiotactic 1,2-polybutadine
DE3064165D1 (en) (e)-5-(2-halogenovinyl)-arabinofuranosyluracil, process for preparation thereof, and uses thereof
DE2862086D1 (en) Antigenic, immunogenic herpes virus subunit and process for preparing it
ZA821621B (en) Dihydrobenzofuran derivatives,a process for their preparation and their use
IL67808A0 (en) Plant-promoting preparations,process for the manufacture thereof and methods for the use thereof
DE3066702D1 (en) 2.5-diketopiperazine-derivative, process for its preparation and its use
YU173588A (en) Process for obtaining vaccine against mycoplasma
ZA874625B (en) Stabilizers for live vaccines,process for their preparation and vaccines containing them
DE3263960D1 (en) Pyrrolidine derivative, process and intermediates for its preparation and medicaments containing it
DE3261973D1 (en) Process for preparing 1,1-dihalo-1,2,2,2,-tetrafluoroethanes
GB2101588B (en) N-acetylneuraminic acid derivatives and process for the preparation thereof.
DE3265055D1 (en) Coumarin derivatives, process for their preparation and their use as dyes
RO87709B (ro) Procedeu pentru prepararea unor 1,1-alcandiol-carboxilati
DE3264316D1 (en) Vaccine against foot-and-mouth disease and colibacillosis, and process for preparing it
DE3479656D1 (en) Rhodanine derivative, process for preparing the same and pharmaceutical composition containing the same
PH18842A (en) Process for preparing the s-methyl n- n- methyl-n-(n,n-disubstituted aminosulfenyl) carbamoyl - oxy thioacetamidate derivative
ZA818145B (en) Process for inactivating foot-and-mouth disease virus
FI823200A7 (fi) N-sulfenyloidut bentsyylisulfonamidit, menetelmä niiden valmistamiseksi ja niiden käyttö mikrobisideina.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee